- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06810115
Respiatory Viral Infections in Patients with Multiple Myeloma
January 30, 2025 updated by: Polona Novak, University Medical Centre Ljubljana
Incidence and Clinical Significance of Respiratory Viral Infections in Patients with Multiple Myeloma
Respiratory viruses are known to be a major cause of morbodity in multiple myeloma patients but prospective long-term sudies are lacking.
We analysed 219 multiple myeloma patients that had 554 nasopharingeal swabs with 58 documented viral episodes.
Respiratory viruses studied were rhinovirus, enterovirus, parainflienza, respirator, syncytial virus, metapneumovirus, coronavirus, bocavirus, influenza A, influenza B. Clinical data were extracted from a prospectively entered database, medical records were reviewed.
We have prospectively studiend patients until May 2019 when we gathered survival data.
Lastly because of Covid-19 pandemic when almost no other viral infections were isolated, we analysed clinical course of respiratory infections in patients with multiple myeloma after the pandemic.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
219
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient with multiple myeloma on observation/receiving treatment at outpatient clinuc
Description
Inclusion Criteria:
- Patients with multiple myeloma
Exclusion Criteria:Other hematological malignancies
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient with multiple myeloma
|
Viral PCR test regardles of symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of respiratory viral infections in patirnts with multiple myeloma
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
October 1, 2024
Study Registration Dates
First Submitted
January 30, 2025
First Submitted That Met QC Criteria
January 30, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 30, 2025
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Neoplasms
- Disease Attributes
- Immune System Diseases
- Neoplasms by Histologic Type
- Hematologic Diseases
- Lymphoproliferative Disorders
- Immunoproliferative Disorders
- Neoplasms, Plasma Cell
- Hemostatic Disorders
- Paraproteinemias
- Blood Protein Disorders
- Hemorrhagic Disorders
- Infections
- Communicable Diseases
- Multiple Myeloma
- Virus Diseases
Other Study ID Numbers
- 83/03/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Viral Infections
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Moscow Department of HealthMoscow State University of Medicine and Dentistry; National Research Center... and other collaboratorsCompletedCovid19 | Respiratory Viral InfectionRussian Federation
-
Peter MacCallum Cancer Centre, AustraliaCompletedCancer | Covid19 | Respiratory Viral InfectionAustralia
-
Stanford UniversityInternational Centre for Diarrhoeal Disease Research, BangladeshNot yet recruitingSARS-CoV2 Infection | Influenza Viral Infections | Respiratory Viral Infection
-
The University of QueenslandGriffith University; The Prince Charles Hospital; Princess Alexandra Hospital... and other collaboratorsCompletedCovid19 | Respiratory Viral InfectionAustralia
-
Hospices Civils de LyonTerminatedCOVID-19 | Viral Pneumonia Human CoronavirusFrance
-
Valenta Pharm JSCCompletedInfluenza | Viral Respiratory Infection | Acute Viral Upper Respiratory InfectionsRussian Federation
-
University of California, Los AngelesCompletedCOVID-19 | Respiratory Viral Infection | Antiviral TreatmentUnited States
-
Bogotá District Health SecretariatNot yet recruitingRespiratory Syncytial Virus Infections | Bronchiolitis, Viral | Severe Acute Respiratory Infection | Viral Respiratory Tract Infection
-
Fondation LenvalWithdrawn
Clinical Trials on Viral PCR test
-
Ellume Pty LtdCompleted
-
Ellume Pty LtdCompleted
-
Centre Hospitalier Universitaire, AmiensCompletedAcute Myeloid LeukemiaFrance
-
University of RochesterRochester General HospitalCompletedRespiratory InfectionsUnited States
-
QuantuMDx Group LtdPathAI; Bright Research Center; New Day DiagnosticsCompleted
-
Kepler University HospitalCompleted
-
University Hospital, GenevaProf Laurent Kaiser; Dr Samuel Cordey; Dr Stavroula Masouridi-Levrat; Prof Christian... and other collaboratorsCompletedRNA Virus Infections | DNA Virus Infections | Hematopietic Stem Cell Transplantation | Blood ViromeSwitzerland
-
American Burn AssociationU.S. Army Medical Research and Development CommandCompleted
-
IgenomixUnknown
-
Assiut UniversityUnknownViral MyocarditisEgypt